📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-21 17:51
0 analysed today
0
Today
133,620
All-time analysed
40,132
Positive
6,284
Negative
79,384
Neutral
7,752
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
26 announcements match the current filters (relevance ≥ 5).
UFLEX Q1 FY27 Transcript: PAT Surges to ₹423.3 Cr on 38% Revenue Growth to ₹5,397.2 Cr
UFLEX reported robust Q1 FY27 performance with consolidated revenue increasing 38% YoY to ₹5,397.2 crore, propelled by international operations. Consolidated EBITDA surged 92% YoY to ₹919.8 crore with margins expanding 480 bps to 17.0%, while PAT rose to ₹423.3 crore from ₹58.0 crore in Q1 FY26. Overseas operations contributed ~91% of incremental EBITDA, benefiting from strong local sourcing demand and localized supply chain de-risking amid regional disruptions. The company incurred ₹478.2 crore in capex during the quarter, with key commissioning milestones achieved in Noida and Mexico.
Confidence: HIGH
What changedUFLEX released the transcript of its Q1 FY27 earnings conference call detailing operational performance, regional volume trends, and capex execution.
Why it mattersDemonstrates strong operational leverage and localized pricing power across overseas plants (Egypt, Mexico, Nigeria), driving multi-quarter high EBITDA margins of 17%.
Q1 FY27 Revenue: ₹53,972 millionQ1 FY27 PAT: ₹4,233 millionEBITDA Margin: 17.0%Q1 Capex Incurred: ₹4,782 millionSales Volume: 173,471 MT
📅 Short termManagement guided for some normalization in Q2 realizations after exceptionally high Q1 spreads, though underlying volumes and margins remain healthy.
📈 Long termThe company's 'Glocal' manufacturing strategy is successfully mitigating global freight disruptions and capturing regional premiums across the Americas, Africa, and the Middle East.
⚠ Risk flags
- Commodity cyclicality and oversupply risks in global packaging film markets.
- Higher debt levels (₹4,268 Cr debt, D/E of 1.26) requiring sustained cash generation.
- Vulnerability to raw material cost spikes linked to crude prices.
Key Highlights
Consolidated revenue jumped 38% YoY to ₹53,972 million, driven by overseas business (80% of incremental revenue).
EBITDA grew 92% YoY to ₹9,198 million with EBITDA margin reaching 17.0% (highest in 21 quarters).
Consolidated PAT reached ₹4,233 million with a net margin of 7.8% compared to ₹580 million in Q1 FY26.
Total sales volumes reached 173,471 MT (+1.7% YoY), led by packaging films volume growth of 4.9% YoY to 136,186 MT.
Incurred ₹4,782 million capex in Q1, with 39,000 MTPA Noida recycling plant and 80M unit Mexico WPP bags commissioned.
👀 What to Watch
Track the ramp-up of newly commissioned Noida recycling and Mexico WPP units, along with progress on the 12-billion-pack Egypt aseptic plant targeted for FY27 commissioning.
UFLEX Q1 FY27 Revenue Jumps 37.6% YoY to ₹5,397.2 Cr; EBITDA Rises 92.1% to ₹919.8 Cr
UFLEX reported strong performance in Q1 FY27 with consolidated revenue rising 37.6% YoY to ₹53,972 million (₹5,397.2 crore) and EBITDA advancing 92.1% YoY to ₹9,198 million (₹919.8 crore). EBITDA margins expanded by 480 bps YoY to 17.0%, driven by operating leverage, higher packaging film realizations, and localized sourcing premiums in overseas subsidiaries. Consolidated PAT reached ₹4,233 million (₹423.3 crore) with a margin of 7.8%. Additionally, the company commissioned a 39,600 MTPA recycling unit in Noida and an 80-million-unit WPP bags facility in Mexico.
Confidence: HIGH
What changedUFLEX published its Q1 FY27 earnings presentation, highlighting sharp margin expansion and the operationalization of new recycling and packaging capacities in India and Mexico.
Why it mattersDemonstrates operating leverage and pricing resilience amid geopolitical and supply chain disruptions, reinforcing profitability through value-added products and international manufacturing hubs.
Consolidated Revenue (Q1 FY27): Rs. 53,972 MnConsolidated EBITDA (Q1 FY27): Rs. 9,198 MnConsolidated PAT (Q1 FY27): Rs. 4,233 MnSales Volume: 173,471 MTCapex in Q1 FY27: Rs. 4,782 Mn
📅 Short termPositive sentiment likely following the 21-quarter high EBITDA margin of 17%, although management flagged potential normalization in realizations during Q2 FY27.
📈 Long termExpansion into recycling (PCR chips), aseptic liquid packaging, and localized production in the Americas and MEA supports structural volume growth and reduces global supply chain risks.
⚠ Risk flags
- Vulnerability to raw material cost spikes (crude-linked feedstocks like MEG and Homo Polypropylene)
- Freight and supply chain disruptions stemming from the West Asia conflict
- Pricing normalization in packaging films over coming quarters
Key Highlights
Consolidated revenue grew 37.6% YoY and 31.7% QoQ to ₹53,972 million in Q1 FY27
EBITDA increased 92.1% YoY to ₹9,198 million, with EBITDA margin widening 480 bps YoY to 17.0%
Consolidated PAT surged to ₹4,233 million (7.8% margin) compared to ₹580 million in Q1 FY26
Commissioned 39,600 MTPA recycling facility at Noida on April 30, 2026, and an 80-million-unit WPP bags plant in Mexico
Net debt stood at ₹73,055 million compared to ₹85,875 million in Q1 FY26
👀 What to Watch
Track management commentary in the earnings call regarding sustainability of elevated realizations, the ramp-up of the Noida recycling and Mexico WPP facilities, and the commissioning timeline of the Egypt aseptic packaging project.
UFLEX Q1 FY27 Net Profit Surges 630% YoY to Rs 4,233 Mn; EBITDA Margin Reaches 17.0%
UFLEX reported a strong operational performance in Q1 FY27, with consolidated revenue rising 37.6% YoY to Rs 53,972 Mn and net profit surging 629.6% YoY to Rs 4,233 Mn. EBITDA increased 92.1% YoY to Rs 9,198 Mn, driving EBITDA margins up by 480 bps YoY to 17.0% (the highest in 21 quarters), aided by better product spreads, operating leverage, and a Rs 825 Mn forex gain. Total sales volume rose 1.7% YoY to 173,471 MT, with overseas revenue contribution increasing to 62% from 56% in Q1 FY26. Growth was underpinned by backward integration at its Panipat PET chips facility and newly commissioned units in Noida and Mexico.
Confidence: HIGH
What changedUFLEX posted a sharp operational turnaround in Q1 FY27 with a 6.3x YoY net profit surge driven by improved film realizations and operating leverage.
Why it mattersHigher product spreads and benefits from captive backward integration (Panipat virgin PET chips) significantly improved profitability, achieving multi-quarter-high EBITDA margins.
Total Income (Q1 FY27): Rs. 53,972 MnConsolidated Net Profit: Rs. 4,233 MnConsolidated EBITDA: Rs. 9,198 MnEBITDA Margin: 17.0%Sales Volume: 173,471 MTForex Gain in EBITDA: Rs. 825 Mn
📅 Short termStrong quarterly performance is expected to support near-term sentiment, although Q2 FY27 may see slight sequential margin moderation due to seasonal trends.
📈 Long termBackward integration in PET chips and global manufacturing expansions across Mexico, Egypt, and India structurally enhance supply security and margin defense against global supply chain volatility.
⚠ Risk flags
- Cyclicality in flexible packaging film spreads and pricing power limits
- Volatile crude-linked raw material prices (PTA, MEG) and supply bottlenecks
- Domestic margin pressure in aseptic packaging due to aggressive imports
Key Highlights
Consolidated net profit surged 629.6% YoY and 116.0% QoQ to Rs 4,233 Mn in Q1 FY27
Revenue from operations increased 37.6% YoY to Rs 53,660 Mn with total sales volumes of 173,471 MT (+1.7% YoY)
EBITDA grew 92.1% YoY to Rs 9,198 Mn with EBITDA margins expanding 480 bps YoY to 17.0%
Overseas markets accounted for 62% of revenue compared to 56% in Q1 FY26
Commissioned a 39,600 MTPA recycling plant in Noida and an 80-million-unit WPP bag plant in Mexico
👀 What to Watch
Monitor packaging film realization sustainability in Q2 FY27 following management's note on potential seasonal normalization, along with commissioning timelines for the upcoming Egypt aseptic packaging plant.
UFLEX Reports Q1 Standalone Revenue of ₹2,344.25 Cr; Contests ₹500.68 Cr Tax Demand
UFLEX reported its Q1 financial results for the quarter ended June 30, 2026, with standalone revenue from operations reaching ₹2,344.25 Cr compared to ₹2,058.01 Cr in the prior-year period. Standalone profit before tax stood at ₹84.09 Cr versus ₹77.46 Cr in Q1 FY26. Operationally, the company commissioned a PET bottles and mixed plastics recycling facility at Noida during the quarter. Separately, the statutory auditor highlighted an ongoing Income Tax demand of ₹500.68 Cr (for AY 2020-21 to 2023-24) stemming from a February 2023 search, which is currently pending adjudication before the ITAT.
Confidence: HIGH
What changedUFLEX declared its Q1 quarterly financial results and announced the successful commissioning of a recycling unit at Noida.
Why it mattersShows operational stability in standalone operations while highlighting contingent exposure to tax litigation equal to ~14.8% of net worth.
Standalone Revenue (Q1): ₹2,344.25 CrStandalone PBT (Q1): ₹84.09 CrContested Tax Demand: ₹500.68 CrTax Demand vs Net Worth: ~14.8%Foreign Subsidiaries Revenue: ₹3,032.11 Cr
📅 Short termStock is likely to react neutrally to the steady operational numbers as the tax dispute remains an ongoing matter already known to markets.
📈 Long termValue addition through circular economy initiatives (recycling) and overseas capacity utilization remain central to long-term profitability amidst packaging film commoditization.
⚠ Risk flags
- Pending tax demand of ₹500.68 Cr under ITAT cross-appeals
- Elevated leverage with D/E ratio at 1.26 (Debt: ₹4,268 Cr)
- Commodity pricing risks and overcapacity in flexible packaging films
Key Highlights
Standalone revenue from operations reached ₹2,344.25 Cr, up 13.9% YoY from ₹2,058.01 Cr in Q1 FY26
Standalone profit before tax and exceptional items came in at ₹84.09 Cr vs ₹77.46 Cr in Q1 FY26
Income Tax demand of ₹500.68 Cr across AY 2020-21 to 2023-24 is currently pending before the ITAT
Commissioned a new PET bottles and mixed plastics recycling unit at Noida, UP
Nine unreviewed foreign subsidiaries recorded revenue of ₹3,032.11 Cr and PAT of ₹546.75 Cr (before elimination)
👀 What to Watch
Track the upcoming full consolidated margin performance and monitor legal updates regarding the ITAT proceedings on the ₹500.68 Cr tax demand.
CRISIL Reaffirms AA- Rating for Rs 4,600 Cr Facilities; Outlook Revised to Negative
CRISIL has reaffirmed UFLEX's long-term credit rating at 'CRISIL AA-' but has revised the outlook from 'Stable' to 'Negative'. This rating applies to bank loan facilities totaling Rs 4,600 crore, which is significant as it exceeds the company's current market capitalization of Rs 3,656 crore. The short-term rating remains unchanged at 'CRISIL A1+'. The negative outlook indicates potential pressure on the company's credit profile, likely stemming from its high debt levels of Rs 4,268 crore and a debt-to-equity ratio of 1.26.
Confidence: HIGH
What changedThe credit rating outlook for UFLEX's long-term debt has been downgraded from 'Stable' to 'Negative', while the underlying rating of 'AA-' was maintained.
Why it mattersA negative outlook is a warning signal that borrowing costs could increase if a formal downgrade occurs. For a company with Rs 4,268 crore in debt, higher interest expenses could significantly impact the net profit margin, which stood at a modest 12.1% (OPM) TTM.
Total Rated Facilities: Rs 4,600 CrRated Facilities vs Market Cap: 125.8%Total Debt: Rs 4,268 CrDebt-to-Equity Ratio: 1.26TTM Revenue: Rs 15,401 Cr
📅 Short termThe revision to a negative outlook may lead to short-term price volatility as it signals increased credit risk and potential future pressure on the balance sheet.
📈 Long termThe company's ability to service its high debt while navigating overcapacity in the packaging film industry remains a structural concern over the next several quarters.
⚠ Risk flags
- High leverage (D/E 1.26)
- Negative credit outlook
- Commoditized industry with limited pricing power
- Exposure to raw material price volatility
Key Highlights
Total bank loan facilities rated at Rs 4,600 crore
Long-term rating reaffirmed at 'CRISIL AA-' with outlook revised to 'Negative'
Short-term rating reaffirmed at 'CRISIL A1+'
Rated facilities represent approximately 126% of the company's current market capitalization
Company carries a total debt of Rs 4,268 crore as per latest financial context
👀 What to Watch
Investors should monitor the specific triggers in the CRISIL rationale that could lead to a formal rating downgrade, particularly margin pressure or delays in capacity utilization at the new Panipat plant. Watch for debt reduction progress in upcoming quarterly results to see if the 'Negative' outlook is stabilized.
80 Million Bags/Year: UFLEX Commences Commercial Production at Mexico Facility
UFLEX Limited has successfully commenced commercial production at its new manufacturing facility in Mexico through its wholly-owned subsidiary, Uflex Woven Bags, S.A. de C.V. The facility, which started operations on July 31, 2026, has an installed capacity of 80 million bags per annum. This expansion is part of the company's 'Glocal' strategy to serve the North American market, potentially benefiting from USMCA trade terms. The project was completed approximately 17 months after its initial announcement in February 2025.
Confidence: HIGH
What changedUFLEX has transitioned its new Mexico-based woven bag manufacturing unit from the construction phase to active commercial production.
Why it mattersThis expansion enhances UFLEX's ability to serve the U.S. and North American markets directly, reducing lead times and potentially mitigating trade-related risks while utilizing its global manufacturing strategy.
Installed capacity: 80 mn bags per annumCommencement date: 31st July, 2026TTM Revenue: ₹ 15401 CrMarket Cap: ₹ 3493 Cr
📅 Short termThe announcement is likely to be viewed positively by the market as it demonstrates timely execution of the expansion plan announced in early 2025.
📈 Long termStructurally positive as it strengthens the company's presence in the Americas and provides a hedge against regional supply chain disruptions, contributing to the targeted 10-12% growth rate.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Ramp-up risk in achieving full capacity utilization
- Exposure to raw material price volatility
- Geopolitical risks affecting trade in the North American region
Key Highlights
Commencement of commercial production achieved on July 31, 2026, at the Mexico facility.
Installed capacity of 80 million bags per annum added to the company's global footprint.
Project executed via wholly-owned subsidiary Uflex Woven Bags, S.A. de C.V., Mexico.
Follows the initial project communication dated February 14, 2025.
👀 What to Watch
Investors should monitor the capacity utilization rates of the new Mexico facility in the next 2-3 quarters to gauge its contribution to the top line. Additionally, watch for improvements in operating margins as the company leverages localized production for the U.S. market.
UFLEX Appoints Arun Kumar Sharma as CFO; Brings 35+ Years of Experience
UFLEX Limited has appointed Mr. Arun Kumar Sharma as its Chief Financial Officer (CFO) and Key Managerial Personnel, effective July 10, 2026. Mr. Sharma is a Chartered Accountant with over 35 years of experience, including a previous leadership stint at Jubilant Group as CFO and Head of Group Treasury. This leadership change is significant as the company manages a substantial TTM revenue of Rs 15,401 crore and a high debt-to-equity ratio of 1.26. His background in treasury management will be critical for UFLEX's capital-intensive operations and debt servicing requirements.
Confidence: HIGH
What changedUFLEX has appointed a new Chief Financial Officer, Mr. Arun Kumar Sharma, to lead its financial and treasury functions.
Why it mattersFor a company with Rs 15,401 crore in TTM revenue and significant leverage, a seasoned CFO with treasury experience is vital for maintaining financial stability and managing global cash flows.
Professional Experience: 35+ yearsEffective Date: July 10, 2026TTM Revenue: Rs 15,401 CrTotal Debt: Rs 4,268 CrDebt/Equity Ratio: 1.26
📅 Short termThe appointment is expected to have a neutral impact on the stock price in the short term as it is a standard leadership transition.
📈 Long termA seasoned CFO with treasury expertise could potentially optimize the company's debt structure and improve financial reporting transparency over the coming years.
Key Highlights
Appointment of Mr. Arun Kumar Sharma as CFO effective July 10, 2026
Mr. Sharma brings over 35 years of experience in finance and leadership roles
Previously served as CFO and Head of Group Treasury at Jubilant Group
Company manages a total debt of Rs 4,268 crore against a net worth of Rs 3,375 crore
New CFO is also authorized to determine materiality of events for SEBI disclosures
👀 What to Watch
Watch for any shifts in the company's debt management strategy or capital allocation plans under the new CFO's leadership, particularly regarding the high 1.26 D/E ratio.
UFLEX Appoints Arun Kumar Sharma as CFO; Brings 35+ Years of Finance Experience
UFLEX Limited has appointed Mr. Arun Kumar Sharma as its Chief Financial Officer (CFO) and Key Managerial Personnel, effective July 10, 2026. Mr. Sharma is a Chartered Accountant with over 35 years of experience, most recently serving as CFO and Head of Group Treasury at Jubilant Group. This leadership change is significant as the company manages a large-scale operation with TTM revenue of ‡15,401 Cr and a substantial debt position of ‡4,268 Cr. His background in treasury management will be relevant given the company's current Debt-to-Equity ratio of 1.26.
Confidence: HIGH
What changedUFLEX has appointed a new Chief Financial Officer, Mr. Arun Kumar Sharma, replacing or filling the vacancy in the KMP position.
Why it mattersFor a company with ‡4,268 Cr in debt and global operations across 150+ countries, a CFO with 35+ years of experience and treasury expertise is critical for maintaining financial stability and managing interest costs.
Experience: 35+ yearsEffective Date: July 10, 2026TTM Revenue: ‡15,401 CrTotal Debt: ‡4,268 CrDebt-to-Equity Ratio: 1.26
📅 Short termThe appointment is unlikely to impact the stock price immediately but provides administrative clarity for the finance function.
📈 Long termA seasoned CFO could potentially optimize the company's balance sheet and treasury operations, which is vital for improving the current low ROCE of 8.0%.
Key Highlights
Appointment of Mr. Arun Kumar Sharma as CFO and KMP effective July 10, 2026
Mr. Sharma brings over 35 years of experience in finance and leadership roles
Previous experience includes serving as CFO and Head of Group Treasury at Jubilant Group
The company maintains a high debt level of ‡4,268 Cr against a net worth of ‡3,375 Cr
New CFO is also authorized to determine materiality of events for SEBI disclosures
👀 What to Watch
Investors should monitor the new CFO's approach to debt management and capital allocation in upcoming quarterly briefings, especially given the current ROCE of 8.0%.
UFLEX Targets 24 Billion Aseptic Pack Capacity by FY2027; FY26 Revenue at Rs 15,513 Cr
UFLEX reported FY26 consolidated revenue of Rs 15,513 Cr with an EBITDA of Rs 1,983.6 Cr. The company is aggressively expanding its high-margin aseptic packaging business, aiming to double capacity from 12 billion to 24 billion packs per annum by FY2027. Key operational milestones include the commissioning of a 1,68,000 MTPA PET chips plant in Panipat and a 5 billion pack expansion in Sanand. Future growth is anchored by a new aseptic plant in Egypt and a 54,000 MTPA BOPP line in Dharwad.
Confidence: HIGH
What changedUFLEX has provided a clear roadmap for doubling its aseptic packaging capacity by FY2027 and confirmed the successful commissioning of the Panipat PET chips facility.
Why it mattersThe shift toward value-added aseptic packaging and backward integration into PET chips is intended to improve margins and reduce reliance on commoditized packaging films, which face oversupply risks.
FY26 Consolidated Revenue: Rs 15,513 CrFY26 Consolidated EBITDA: Rs 1,983.6 CrAseptic Capacity Target (FY27): 24 billion packsPanipat PET Chips Capacity: 1,68,000 MTPADebt to Equity Ratio: 1.26
📅 Short termThe market may react positively to the recovery in BOPET and BOPP pricing trends noted in Q4 FY26 and the clear growth targets for FY27.
📈 Long termStructural shift towards value-added aseptic packaging and recycling (Project Plastic Fix) could re-rate the business if execution meets the 24 billion pack target by FY2027.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- High debt levels (Rs 4,268 Cr)
- Raw material price sensitivity (crude-linked PTA/MEG)
- Global supply chain disruptions impacting freight costs
Key Highlights
Global manufacturing capacity stands at 1,387,910 MTPA across 18 plants in 9 countries
Aseptic liquid packaging capacity increased to 12 billion packs/year from 7 billion following Sanand expansion
Targeting 24 billion aseptic carton packs/year nameplate capacity by FY2027 to drive margins
FY26 consolidated revenue reached Rs 15,513 Cr, representing a 13% CAGR since 2020
New 1,68,000 MTPA vPET chips plant in Panipat commenced production in April 2024
👀 What to Watch
Monitor the commissioning timeline of the Egypt aseptic plant and the Dharwad BOPP line, as these are key to margin improvement. Watch for the impact of raw material price volatility (PTA/MEG) on operating margins given the company's high debt levels.
UFLEX Recommends Rs 3 Dividend for FY 2025-26; Sets Record Date for June 26
UFLEX Limited has recommended a dividend of Rs 3 per equity share (30% of face value) for the financial year ended March 31, 2026. The company has fixed June 26, 2026, as the record date to determine shareholder eligibility for the payout. The dividend is subject to approval at the upcoming Annual General Meeting on July 29, 2026, and will be paid by August 27, 2026. Shareholders are required to submit tax-related documentation by the record date to ensure appropriate TDS rates are applied.
Key Highlights
Dividend of Rs 3 per equity share (30% of face value) recommended for FY 2025-26
Record date for dividend eligibility set for June 26, 2026
TDS of 10% applicable for resident shareholders with PAN; 20% for those without valid PAN or Aadhaar linking
Exemption from TDS for individual shareholders if the total dividend amount does not exceed Rs 10,000
Dividend payment to be processed on or before August 27, 2026, following AGM approval
👀 What to Watch
Shareholders should ensure their PAN is updated and linked to Aadhaar, and submit necessary tax exemption forms by June 26, 2026, to avoid higher tax deductions.
UFlex Reports Strong Q4FY26: EBITDA Jumps 36.3% QoQ to Rs 6,265 Million
UFlex delivered a robust Q4FY26 performance with consolidated revenue reaching Rs 40,973 million, a 12.8% sequential increase. Profitability saw a significant boost as EBITDA margins expanded to 15.3%, the highest in 14 quarters, driven by improved realizations and a better product mix. The company's international business now contributes 57% of total revenue, supported by a 23% sequential volume growth in the Americas. Management remains optimistic for FY27, expecting growth from new capacities in Egypt, Mexico, and India.
Key Highlights
Q4 EBITDA surged 36.3% QoQ and 31.8% YoY to Rs 6,265 million, with margins expanding to 15.3%.
Consolidated sales volume for Q4 increased 10.3% sequentially to 166,879 MT.
Aseptic packaging business recorded 7.97 billion packs for FY26, showing resilience despite seasonal disruptions.
Americas region led volume growth with a 23% sequential increase, while international revenue share rose to 57%.
FY26 consolidated revenue stood at Rs 155,130 million with a 70 bps expansion in EBITDA margin to 12.8%.
👀 What to Watch
Investors should maintain a positive outlook as the company achieves multi-quarter high margins and successfully ramps up international volumes. Key monitors include the utilization levels of the new Dharwad BOPP line and the Egypt aseptic facility in FY27.
UFLEX Q4 FY26 Revenue Rises 5.7% YoY to Rs 40,973 Mn; EBITDA Margins Expand to 15.3%
UFLEX reported a strong Q4 FY26 with revenue reaching Rs 40,973 million, driven by a 10.3% sequential volume growth. EBITDA margins saw a significant expansion of 300 bps YoY to 15.3%, aided by improved product mix and inventory optimization. The company is aggressively expanding its global footprint with major capex projects in Egypt and Mexico, alongside a capacity hike in its Sanand aseptic packaging facility from 7 billion to 12 billion packs per annum. Despite domestic FMCG moderation, the company benefited from improved realizations in the packaging films segment due to global supply chain disruptions.
Key Highlights
Q4 FY26 Revenue grew 12.8% QoQ to Rs 40,973 Mn, while FY26 revenue reached Rs 155,130 Mn.
EBITDA for Q4 jumped 31.8% YoY to Rs 6,265 Mn, with margins expanding to 15.3% from 12.3% YoY.
Aseptic packaging capacity at Sanand increased from 7 billion to 12 billion packs per annum during FY26.
Total Q4 sales volumes rose 10.3% QoQ to 166,879 MT, led by growth in both Packaging Films and Packaging segments.
Significant capex of Rs 7,070 Mn incurred in Q4 for major projects in Egypt (Aseptic), Mexico (WPP), and India (Recycling and BOPP).
👀 What to Watch
Investors should monitor the commissioning of the Egypt and Mexico plants in H1 FY27, which are expected to drive the next phase of volume growth. The sharp recovery in EBITDA margins is a positive signal, though geopolitical risks affecting raw material supply chains remain a factor to watch.
UFLEX Q4 FY26 EBITDA Jumps 31.8% YoY to Rs 6,265 Mn; Margins Expand to 15.3%
UFLEX Limited reported a strong performance for Q4 FY26, with consolidated revenue growing 5.7% YoY to Rs 40,973 Mn. The company achieved significant margin expansion, with EBITDA margins rising 300 bps YoY to 15.3%, driven by improved realizations and operational excellence despite geopolitical headwinds. Normalized PAT for the quarter surged 105.5% YoY to Rs 2,026 Mn. For the full fiscal year 2026, revenue reached Rs 155,130 Mn with a normalized PAT of Rs 3,362 Mn, up 5% YoY.
Key Highlights
Q4 FY26 EBITDA increased 31.8% YoY to Rs 6,265 Mn, with margins expanding by 300 bps to 15.3%.
Normalized PAT for Q4 FY26 grew by 105.5% YoY to Rs 2,026 Mn, showing a sharp recovery from previous quarters.
Sales volume for the quarter stood at 166,879 MT, representing a 10.3% sequential (QoQ) growth.
Aseptic Liquid Packaging sales volumes grew 15.9% QoQ to 2.08 billion packs in Q4 FY26.
New capacities including a 12 billion pack aseptic facility in Egypt and a 36,000 MTPA rPET plant in Noida are on track for commissioning.
👀 What to Watch
Investors should take note of the significant margin recovery and the company's ability to navigate supply chain disruptions in the packaging film segment. The upcoming commissioning of large-scale international capacities in Egypt and Mexico suggests a positive outlook for volume-led growth in FY27.
UFLEX Recommends ₹3 Dividend and Re-appoints Independent Director; FY26 Results Approved
UFLEX Limited has approved its audited financial results for the fiscal year ended March 31, 2026, receiving an unmodified audit opinion. The Board has recommended a dividend of ₹3 per equity share (30% of face value), with a record date of June 26, 2026. Additionally, the company has approved the re-appointment of Mr. Paresh Nath Sharma as an Independent Director for a second five-year term starting February 2027. Investors should note an 'Emphasis of Matter' regarding ongoing income tax litigation and search proceedings from 2023, which are currently pending adjudication.
Key Highlights
Recommended a dividend of ₹3 per equity share (30%) for the financial year ended March 31, 2026.
Approved audited standalone and consolidated financial results for FY26 with an unmodified audit opinion.
Re-appointed Mr. Paresh Nath Sharma as Independent Director for a second 5-year term (2027-2032).
Set the record date for dividend and AGM as June 26, 2026, with payment by August 27, 2026.
Disclosed ongoing income tax disputes for AY 2020-21 to 2022-23 currently pending before the ITAT.
👀 What to Watch
Investors should note the record date of June 26, 2026, to be eligible for the ₹3 dividend and monitor the legal developments regarding the pending income tax assessments mentioned in the audit report.
UFLEX Recommends ₹3 Dividend; Sets June 26, 2026, as Record Date
UFLEX Limited has recommended a dividend of ₹3 per equity share (30% of face value) for the financial year ended March 31, 2026. The company has fixed June 26, 2026, as the record date to determine eligibility for the dividend payment. The dividend is subject to shareholder approval at the upcoming Annual General Meeting scheduled for July 29, 2026. Additionally, the company reported audited financial results for FY26 and noted ongoing tax litigation regarding search proceedings from 2023.
Key Highlights
Recommended a dividend of ₹3 per equity share of ₹10 each (30%) for FY 2025-26.
Fixed June 26, 2026, as the Record Date for the purpose of dividend payment.
Dividend payment will be completed on or before August 27, 2026, if approved by shareholders.
Book closure period set from June 27, 2026, to July 3, 2026.
Reported ongoing income tax appeals for AY 2020-21 to 2022-23 currently pending before the ITAT.
👀 What to Watch
Investors interested in the dividend should ensure they hold shares before the ex-dividend date, which typically precedes the June 26 record date. Long-term investors should also monitor the resolution of the pending income tax litigation mentioned in the auditor's report.
UFLEX Recommends ₹3 Dividend and Approves Audited FY26 Financial Results
UFLEX Limited has approved its audited standalone and consolidated financial results for the fiscal year ended March 31, 2026, with auditors issuing an unmodified opinion. The Board recommended a dividend of ₹3 per equity share (30% of face value), subject to shareholder approval at the upcoming AGM on July 29, 2026. While the company continues to expand with new subsidiaries in Egypt and Qatar, it remains involved in ongoing income tax litigation following search proceedings in 2023, which management believes will be resolved in their favor.
Key Highlights
Recommended a dividend of ₹3 per equity share (30%) for the financial year ended March 31, 2026.
Set June 26, 2026, as the record date for dividend eligibility and the Annual General Meeting.
Statutory auditors provided an unmodified opinion on the financial results, though included an 'Emphasis of Matter' regarding pending income tax demands.
Approved the re-appointment of Paresh Nath Sharma as an Independent Director for a second five-year term starting February 2027.
Consolidated results now include new entities: Flex Egypt Industries (w.e.f. April 2025) and Flex International LLC, Qatar (w.e.f. May 2025).
👀 What to Watch
Investors should track the stock for the upcoming dividend record date of June 26 and monitor the ITAT proceedings regarding the tax demands mentioned in the audit report.
UFLEX Commissions 39,600 MTA Recycling Unit for PET Bottles and Mixed Plastics in Noida
UFLEX Limited has successfully commissioned its new recycling facility in Noida as of April 30, 2026. The unit is designed to process PET bottles and mixed plastics with a significant capacity of 39,600 MTA. This project, initially announced in February 2025, strengthens the company's commitment to the circular economy and sustainable packaging. The commissioning marks a key milestone in the company's operational expansion and ESG initiatives.
Key Highlights
Successfully commissioned the recycling unit in Noida on April 30, 2026
Total processing capacity of the new unit stands at 39,600 MTA
Facility is equipped to handle both PET bottles and mixed plastic waste
Project completion follows the initial announcement made on February 14, 2025
👀 What to Watch
Investors should view this as a positive development that enhances UFLEX's ESG profile and operational capacity. Monitor the impact of this facility on the company's green product portfolio and overall margins in the coming quarters.
UFLEX Targets 24 Billion Aseptic Pack Capacity by FY26; Plans Major Global Expansions
UFLEX Limited is aggressively scaling its high-margin aseptic liquid packaging business, aiming to double its capacity to 24 billion packs per year by FY2026. The company is set to commission a new 12 billion pack plant in Egypt and an 80 million capacity WPP bag facility in Mexico during 2026. With a global manufacturing capacity of over 1.35 million MTPA, UFLEX is well-positioned to capitalize on India's packaging market, which is projected to grow at a 10.2% CAGR through 2027. Recent trends show a broad-based decline in raw material costs like PTA and MEG, which may support margin recovery.
Key Highlights
Aiming to reach 24 billion aseptic carton packs per year capacity by FY2026 from the current 12 billion.
Total global manufacturing capacity stands at 1,351,910 MTPA across 17 units and 150+ countries.
Commissioning a 12 billion pack aseptic plant in Egypt and an 80 million WPP bag facility in Mexico in 2026.
Setting up two new recycling plants in Noida for PCR PET and PCR MLP to enhance sustainability profile.
India's packaging market is forecasted to grow from $102 billion in 2023 to $150 billion by 2027.
👀 What to Watch
Investors should track the timely commissioning of the Egypt and Mexico facilities as they are critical for the next leg of growth. The shift toward high-margin aseptic packaging and recycled plastics (PCR) is a positive strategic move for long-term value creation.
UFLEX Q3 FY26: PAT at Rs 361 Mn; Aseptic Packaging Volumes Rise to 1.8 Bn Packs
UFLEX reported Q3 FY26 revenue of Rs 36,329 million, a 3.8% YoY decline due to volume softness and pricing pressure, but achieved a PAT of Rs 361 million, up 34% sequentially. The aseptic packaging business showed steady growth with volumes rising to 1.8 billion packs in Q3, and management has set an ambitious target of 8.5 billion packs for FY27. Management indicated that debt levels have likely peaked as major expansion projects in Egypt, India, and Mexico near completion. Normalized EBITDA margins improved to 12.1%, a 200 bps expansion quarter-on-quarter, driven by operational discipline.
Key Highlights
Q3 FY26 PAT stood at Rs 361 million with an EPS of Rs 5.01 per share.
Normalized EBITDA grew 12.8% sequentially to Rs 4,395 million with margins at 12.1%.
Aseptic liquid packaging volumes grew 4.4% in 9M FY26 to 5.9 billion packs.
Three major projects in Egypt, India, and Mexico are nearing the commissioning stage.
Management expects aseptic packaging sales to reach 8.5 billion packs in the next fiscal year.
👀 What to Watch
Investors should focus on the commissioning of the Egypt and Mexico projects as key drivers for EBITDA growth and debt reduction. The recovery in film pricing and growth in the high-margin aseptic segment provide a constructive outlook for the stock.
UFLEX to Acquire 28% Stake in Ampin C&I Power for Rs 6.67 Cr for Captive Hybrid Power
UFLEX Limited has entered into a Power Purchase Agreement and Share Subscription Agreement to acquire a 28% equity stake in Ampin C&I Power Twenty-Seven Private Limited. The investment, totaling Rs 6.67 crore, is aimed at sourcing hybrid (Solar + Wind) power on a long-term basis. This move follows the captive power plant policy, which requires users to hold at least a 26% stake in the generating entity. The target company is a newly incorporated entity focused on renewable energy generation in India.
Key Highlights
Acquisition of 28% equity stake involving 66,66,000 shares at Rs 10 each.
Total cash consideration for the investment is Rs 6.67 crore.
Investment facilitates long-term access to hybrid (Solar and Wind) power for captive use.
Target entity is a newly incorporated company (July 2025) with zero current turnover.
Transaction is expected to be completed within 7 business days.
👀 What to Watch
This is a strategic move to lower long-term energy costs and improve ESG ratings. Investors should view this as a positive step toward operational efficiency and sustainability.
